| Primary |
| Diagnostic Procedure |
31.1% |
| Product Used For Unknown Indication |
27.9% |
| Drug Use For Unknown Indication |
15.9% |
| Coronary Artery Disease |
3.5% |
| Chest Pain |
2.5% |
| Pulmonary Embolism |
2.5% |
| Angina Pectoris |
2.2% |
| Prostate Cancer |
1.5% |
| Abdominal Pain |
1.4% |
| Aortic Aneurysm |
1.4% |
| Computerised Tomogram |
1.4% |
| Hypertension |
1.4% |
| Angiogram |
1.2% |
| Therapeutic Embolisation |
1.2% |
| Catheterisation Cardiac |
1.0% |
| Scan With Contrast |
1.0% |
| Acute Coronary Syndrome |
0.8% |
| Haematuria |
0.8% |
| Colon Cancer |
0.7% |
| Dyspnoea |
0.7% |
|
| Vomiting |
12.4% |
| Renal Failure Acute |
11.2% |
| Urticaria |
9.2% |
| Anaphylactoid Reaction |
6.0% |
| Anaphylactoid Shock |
5.6% |
| Pyrexia |
5.6% |
| Rash |
5.6% |
| Pruritus |
5.2% |
| Loss Of Consciousness |
4.4% |
| Coronary No-reflow Phenomenon |
4.0% |
| Hypersensitivity |
3.6% |
| Toxic Skin Eruption |
3.6% |
| Chills |
3.2% |
| Renal Failure |
3.2% |
| Tachycardia |
3.2% |
| Throat Tightness |
3.2% |
| Blood Creatinine Increased |
2.8% |
| Nephropathy Toxic |
2.8% |
| Rash Maculo-papular |
2.8% |
| Respiratory Arrest |
2.8% |
|
| Secondary |
| Diagnostic Procedure |
21.1% |
| Drug Use For Unknown Indication |
17.4% |
| Product Used For Unknown Indication |
12.3% |
| Angiogram |
8.7% |
| Nuclear Magnetic Resonance Imaging |
8.6% |
| Prostate Cancer |
3.3% |
| Computerised Tomogram |
3.2% |
| Unevaluable Event |
3.0% |
| Angioplasty |
2.8% |
| Coronary Artery Disease |
2.6% |
| Premedication |
2.2% |
| Intravenous Catheter Management |
1.9% |
| Multiple Sclerosis |
1.9% |
| Osteoporosis |
1.9% |
| Pain |
1.9% |
| Arteriogram Coronary |
1.6% |
| Cardiac Failure Congestive |
1.5% |
| Meningitis |
1.5% |
| Depression |
1.3% |
| Ill-defined Disorder |
1.3% |
|
| Vomiting |
15.8% |
| Cerebrovascular Accident |
14.3% |
| Urticaria |
10.8% |
| Renal Failure Acute |
7.4% |
| Pruritus |
4.9% |
| Coronary No-reflow Phenomenon |
4.4% |
| Rash |
4.4% |
| Nephrogenic Systemic Fibrosis |
3.4% |
| Rash Maculo-papular |
3.4% |
| Toxic Skin Eruption |
3.4% |
| Tremor |
3.4% |
| Dermatitis Allergic |
3.0% |
| Swelling Face |
3.0% |
| Throat Irritation |
3.0% |
| Weight Decreased |
3.0% |
| Acute Generalised Exanthematous Pustulosis |
2.5% |
| Hypersensitivity |
2.5% |
| Hypotension |
2.5% |
| Pain |
2.5% |
| Pyrexia |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
28.7% |
| Nuclear Magnetic Resonance Imaging |
18.2% |
| Angiogram |
9.0% |
| Drug Use For Unknown Indication |
7.8% |
| Catheterisation Cardiac |
7.4% |
| Coronary Artery Bypass |
7.4% |
| Pain |
2.6% |
| Arteriogram Coronary |
2.0% |
| Pancreatitis |
1.9% |
| Hypertension |
1.8% |
| Aortic Valve Replacement |
1.6% |
| Drug Therapy |
1.5% |
| Nuclear Magnetic Resonance Imaging Abdominal |
1.5% |
| Venogram |
1.4% |
| Diabetes Mellitus |
1.3% |
| Fistulogram |
1.3% |
| Pulmonary Hypertension |
1.3% |
| Arteriogram |
1.2% |
| Stent Placement |
1.2% |
| Anxiety |
1.1% |
|
| Nephrogenic Systemic Fibrosis |
12.1% |
| Skin Tightness |
9.8% |
| Fear |
8.3% |
| Injury |
8.3% |
| Unevaluable Event |
8.3% |
| Skin Ulcer |
7.6% |
| Pain |
6.1% |
| Vision Blurred |
5.3% |
| Anxiety |
4.5% |
| Venous Insufficiency |
4.5% |
| Emotional Distress |
3.8% |
| Ventricular Tachycardia |
3.8% |
| Anhedonia |
3.0% |
| Renal Failure |
3.0% |
| Renal Injury |
3.0% |
| Renal Impairment |
2.3% |
| Autoimmune Thrombocytopenia |
1.5% |
| Cardiac Arrest |
1.5% |
| Depression |
1.5% |
| Idiopathic Urticaria |
1.5% |
|
| Interacting |
| Drug Use For Unknown Indication |
60.0% |
| Arteritis Obliterans |
20.0% |
| Hypertension |
20.0% |
|
| Renal Tubular Necrosis |
50.0% |
| Renal Failure Acute |
25.0% |
| Weight Decreased |
25.0% |
|
